FME:ETR
Fresenius Medical Care AG
39,57 €
arrow_upward
+0,94%(+0,37) 1D
30-сен., 17:35:04 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FME...
Open
39,64 €
High
39,84 €
Low
39,23 €
Mkt. cap
10,51 млд
Avg. vol.
799,08 миң
Volume
1,03 млн
Dividend
3,77%
Quarterly dividend
0,37 €
Ex-dividend date
2026-ж., 22-май
P/E ratio
11,90
52-wk high
47,86 €
52-wk low
34,57 €
EPS
3,33 €
Shares outstanding
268,56 млн
No. of employees
107 миң
Open
39,64 €
High
39,84 €
Low
39,23 €
Mkt. cap
10,51 млд
Avg. vol.
799,08 миң
Volume
1,03 млн
Dividend
3,77%
Quarterly dividend
0,37 €
Ex-dividend date
2026-ж., 22-май
P/E ratio
11,90
52-wk high
47,86 €
52-wk low
34,57 €
EPS
3,33 €
Shares outstanding
268,56 млн
No. of employees
107 миң
News stories
From web sources and news partners
AD HOC NEWS
·
15 саат мурун
Fresenius Medical Care stock trades at EUR 39.48, plus 0.20 percent versus EUR 39.40
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees107 миң
Founded1996
Headquarters-
SectorHealth care provider
Websitefreseniusmedicalcare.com